These observations complemented the findings of the present study that the inhibition of miR-301a and elevation of the expression levels of TSC1 in mice reduced pulmonary fibrosis, suggesting that prophylactic anti-miR-301a administration protected animals from bleomycin-induced pulmonary fibrosis. Here, TSC1 is linked to pulmonary fibrosis.